AFP and hepatocellular carcinoma: Its value may lie in AFP-negative HCC patientswhereGPC-3 displays a sensitivity of 54.6% and a specificity of 76% among AFP-negative patients (AFP < 400ug/L) was observed (Li et al. 2013) (Table 1).